Lisa Hartman M.D., Ildar Nurmeev M.D., Pavel Svirin M.D., Kevin D, Wolter, M.D., Jean Li Yan M.S., Darshana Jani M.Sc., Neil Goldenberg M.D., Ph.D., and Nancy Sherman M.D.
Brief Report: A Phase 2 Pharmacodynamic Dose-finding, Safety, and Efficacy study of Dalteparin for Pediatric Venous Thromboembolism Treatment in Children with and without Cancer
Leonora R. Slatnick, MD, Katie Angione, MS, CGC, Lisa Hartman, MD. Precursor B-Cell Acute Lymphoblastic Leukemia in a patient with Bainbridge-Ropers Syndrome.
Hartman LR, Nurmeev I, Svirin P, Wolter KD, Yan JL, Jani D, Goldenberg NA, Sherman N. A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancer. Pediatr Blood Cancer. 2022 Aug;69(8):e29764. PubMed PMID: 35678616
Slatnick LR, Angione K, Hartman L. Precursor B-cell acute lymphoblastic leukemia in a pediatric patient with Bainbridge-Ropers syndrome. Pediatr Blood Cancer. 2023 Jan;70(1):e29873. PubMed PMID: 35733401
Slatnick LR, Angione K, Hartman L. Precursor B-cell acute lymphoblastic leukemia in a pediatric patient with Bainbridge-Ropers syndrome. Pediatr Blood Cancer. 2023 Jan;70(1):e29873. PubMed PMID: 35733401
Hartman LR, Nurmeev I, Svirin P, Wolter KD, Yan JL, Jani D, Goldenberg NA, Sherman N. A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancer. Pediatr Blood Cancer. 2022 Aug;69(8):e29764. PubMed PMID: 35678616